Newlink Genetics is a biopharmaceutical company based in Ames, IA that focuses on developing novel immunotherapy treatments for cancer. The company conducts research and clinical trials to advance innovative therapies that aim to improve patient outcomes.
With a commitment to addressing unmet medical needs, Newlink Genetics strives to harness the power of the immune system to combat various forms of cancer. Through its cutting-edge approach, the company aims to make a meaningful impact in the field of oncology.
Generated from their business information